Beta Bionics (BBNX) Competitors $19.11 -0.16 (-0.83%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX vs. NVST, LIVN, WRBY, LMAT, NVCR, ENOV, CNMD, EYE, LQDA, and CDREShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), LeMaitre Vascular (LMAT), NovoCure (NVCR), Enovis (ENOV), CONMED (CNMD), National Vision (EYE), Liquidia (LQDA), and Cadre (CDRE). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Its Competitors Envista LivaNova Warby Parker LeMaitre Vascular NovoCure Enovis CONMED National Vision Liquidia Cadre Beta Bionics (NASDAQ:BBNX) and Envista (NYSE:NVST) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Is BBNX or NVST more profitable? Beta Bionics has a net margin of 0.00% compared to Envista's net margin of -44.56%. Envista's return on equity of 3.86% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Envista -44.56%3.86%2.21% Does the MarketBeat Community prefer BBNX or NVST? Envista received 30 more outperform votes than Beta Bionics when rated by MarketBeat users. However, 63.64% of users gave Beta Bionics an outperform vote while only 33.94% of users gave Envista an outperform vote. CompanyUnderperformOutperformBeta BionicsOutperform Votes763.64% Underperform Votes436.36% EnvistaOutperform Votes3733.94% Underperform Votes7266.06% Do analysts rate BBNX or NVST? Beta Bionics presently has a consensus target price of $23.13, suggesting a potential upside of 21.01%. Envista has a consensus target price of $20.23, suggesting a potential upside of 5.34%. Given Beta Bionics' stronger consensus rating and higher probable upside, research analysts clearly believe Beta Bionics is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73Envista 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33 Which has stronger valuation and earnings, BBNX or NVST? Beta Bionics has higher earnings, but lower revenue than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$69.83M11.87N/AN/AN/AEnvista$2.50B1.30-$1.12B-$6.53-2.94 Does the media prefer BBNX or NVST? In the previous week, Beta Bionics had 7 more articles in the media than Envista. MarketBeat recorded 9 mentions for Beta Bionics and 2 mentions for Envista. Envista's average media sentiment score of 0.75 beat Beta Bionics' score of 0.65 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryBeta Bionics beats Envista on 7 of the 12 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$828.53M$4.40B$5.56B$8.61BDividend YieldN/A42.67%5.27%4.19%P/E RatioN/A28.4427.1720.06Price / Sales11.8771.85409.72157.10Price / CashN/A51.0838.2534.64Price / BookN/A5.917.064.70Net IncomeN/A$67.63M$3.23B$247.88M7 Day Performance-1.75%2.05%2.68%2.20%1 Month Performance38.58%18.79%12.02%9.44%1 Year PerformanceN/A19.13%31.24%14.72% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta BionicsN/A$19.11-0.8%$23.13+21.0%N/A$828.53M$69.83M0.00294Gap UpNVSTEnvista3.3655 of 5 stars$18.69-0.3%$20.23+8.3%+5.5%$3.17B$2.50B-2.8812,700Positive NewsLIVNLivaNova3.0945 of 5 stars$44.85+0.8%$59.29+32.2%-9.9%$2.45B$1.28B106.792,900WRBYWarby Parker2.0628 of 5 stars$21.19+4.0%$22.88+8.0%+31.7%$2.21B$795.09M-78.483,030Positive NewsLMATLeMaitre Vascular2.9015 of 5 stars$83.40+1.0%$97.83+17.3%+7.7%$1.88B$226.26M45.57490Positive NewsNVCRNovoCure4.0451 of 5 stars$16.45-1.6%$32.83+99.6%-14.4%$1.83B$621.71M-11.751,320ENOVEnovis2.6987 of 5 stars$31.59-0.7%$58.00+83.6%-25.7%$1.80B$2.15B-14.436,800CNMDCONMED4.0294 of 5 stars$56.53-0.1%$62.20+10.0%-20.2%$1.75B$1.32B13.334,100EYENational Vision3.2426 of 5 stars$20.86-0.1%$17.75-14.9%+46.7%$1.65B$1.85B-104.2914,000Positive NewsLQDALiquidia3.7461 of 5 stars$18.02+2.4%$26.67+48.0%+8.2%$1.54B$14.14M-11.0650Trending NewsAnalyst ForecastOptions VolumeHigh Trading VolumeCDRECadre2.9618 of 5 stars$33.99-0.3%$37.00+8.9%+7.1%$1.38B$559.81M40.952,240 Related Companies and Tools Related Companies Envista Competitors LivaNova Competitors Warby Parker Competitors LeMaitre Vascular Competitors NovoCure Competitors Enovis Competitors CONMED Competitors National Vision Competitors Liquidia Competitors Cadre Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
